<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04936100</url>
  </required_header>
  <id_info>
    <org_study_id>99424</org_study_id>
    <nct_id>NCT04936100</nct_id>
  </id_info>
  <brief_title>Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity</brief_title>
  <official_title>Assessment of the Validity, Reliability, and Feasibility of Two Smartphone Applications for Testing the Visual Acuity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shahid Beheshti University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shahid Beheshti University of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visual acuity (VA) is the most common measure of visual function globally. In clinical&#xD;
      settings and during screening events, VA is an important measure to quantify changes in&#xD;
      vision over time. Additionally, in the context of epidemiological studies and&#xD;
      population-based surveys, VA is a critical measure to determine the presence and degree of&#xD;
      vision impairment and to report on the indicators of effective eye care service coverage&#xD;
      (i.e. refractive error and cataract surgery), that are currently considered by World Health&#xD;
      Organization (WHO) for monitoring progress towards the Universal Health Coverage.&#xD;
&#xD;
      There are numerous applications for assessing VA; however, the number of validated&#xD;
      applications is limited. In this study, we aim to evaluate the external validity, intra- and&#xD;
      inter-observer reliability, and feasibility of two applications (&quot;Easy Vision&quot; and &quot;Peek&#xD;
      Acuity&quot;) for testing the visual acuity.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 23, 2021</start_date>
  <completion_date type="Anticipated">January 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 23, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance visual acuity assessment with Easy Vision versus Peek Acuity versus conventional distance visual acuity chart</measure>
    <time_frame>Through study completion [an average of 6 months]</time_frame>
    <description>To assess the agreement between two smartphone-based evaluation of distance visual acuity (LogMAR unit) with Easy Vision and Peek Acuity and a conventional distance visual acuity chart (Tumbling E optotype)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Near visual acuity assessment with Easy Vision versus Peek Acuity versus conventional near visual acuity chart</measure>
    <time_frame>Through study completion [an average of 6 months]</time_frame>
    <description>To assess the agreement between two smartphone-based evaluation of near visual acuity (LogMAR unit) with Easy Vision and Peek Acuity and a conventional near visual acuity chart (Handheld chart: Tumbling E Near Point Vision Chart)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Vision Impairment and Blindness</condition>
  <arm_group>
    <arm_group_label>Visual acuity assessment using &quot;Vision Screening module&quot; of &quot;Easy Vision&quot; application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Visual acuity assessment using &quot;Test Yourself module&quot; of &quot;Easy Vision&quot; application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Visual acuity assessment using &quot;Peek Acuity&quot; application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Visual acuity assessment using the conventional methods</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Assessment of distance and near visual acuity using &quot;Vision Screening module&quot; of &quot;Easy Vision&quot; application</intervention_name>
    <description>The presenting visual acuity will be assessed using the Vision Screening module of the &quot;Easy Vision&quot; application.</description>
    <arm_group_label>Visual acuity assessment using &quot;Vision Screening module&quot; of &quot;Easy Vision&quot; application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Assessment of distance and near visual acuity using &quot;Test Yourself module&quot; of &quot;Easy Vision&quot; application</intervention_name>
    <description>The presenting visual acuity will be assessed using the Test Yourself module of the &quot;Easy Vision&quot; application.</description>
    <arm_group_label>Visual acuity assessment using &quot;Test Yourself module&quot; of &quot;Easy Vision&quot; application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Assessment of distance and near visual acuity using &quot;Peek Acuity&quot; application</intervention_name>
    <description>The presenting visual acuity will be assessed using the &quot;Peek Acuity&quot; application.</description>
    <arm_group_label>Visual acuity assessment using &quot;Peek Acuity&quot; application</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Assessment of distance and near visual acuity using the conventional methods</intervention_name>
    <description>The presenting visual acuity will be assessed using the conventional methods [&quot;Chart: Tumbling E optotype&quot; for assessing distance visual acuity and &quot;Handheld chart: Tumbling E Near Point Vision Chart&quot; for assessing near visual acuity]</description>
    <arm_group_label>Visual acuity assessment using the conventional methods</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
        • Age ≥10 years old&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        • Subjects who are not able to respond to the examiner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <contact>
      <last_name>Sare Safi, PhD</last_name>
      <phone>+98 21 2258 5952</phone>
      <email>saresafi.s@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mohammad Ali Javadi, MD</last_name>
      <phone>+98 21 2258 5952</phone>
      <email>ma_javadi@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Alireza Ramezani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saeed Karimi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 13, 2021</last_update_submitted>
  <last_update_submitted_qc>June 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shahid Beheshti University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Zahra Rabbani Khah</investigator_full_name>
    <investigator_title>Head of Ophthalmic Research Center</investigator_title>
  </responsible_party>
  <keyword>Visual acuity</keyword>
  <keyword>Smartphone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blindness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

